Results 131 to 140 of about 1,093,324 (351)

Impact of Heart Failure and Chronic Kidney Disease on All‐Cause Mortality in Patients Undergoing Coronary Angiography: Results From the Finnish Kardio Multicentre Registry

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Heart failure (HF) and chronic kidney disease (CKD) are common comorbidities among patients undergoing coronary angiography. Both conditions are associated with increased risk of adverse cardiovascular outcomes and mortality. However, the joint prognostic impact of HF and CKD in this patient population remains unclear. Aims We aimed
Jari A. Laukkanen, Jaakko Immonen, Jussi Hernesniemi, Mari Merentie, Ashish H. Shah, Markku Eskola, Sudhir Kurl, Setor K. Kunutsor   +7 more
wiley   +1 more source

Calcific aortic stenosis and congenital bicuspid aortic valves. [PDF]

, 1968
M Campbell
openalex   +1 more source

Feasibility and Safety of Transfemoral Aortic Valve Replacement Using Local Anesthesia in the Catheterization Suite Versus General Anesthesia in the Operation Theater

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background For over a decade, transfemoral transcatheter aortic valve replacements (TF‐TAVR) have been performed at the University Hospital of Nancy. A minimalistic approach to TF‐TAVR, conducted without general anesthesia and entirely percutaneously in a catheterization suite (simplified approach), has been reported to be as safe and ...
Guillaume Abadié, Pierre Adrien Metzdorf, Giuseppe Lauria, Jeanne Varlot, Mazen Elfarra, Florian Eggenspieler, Juan‐Pablo Maureira, Batric Popovic, Edoardo Camenzind   +8 more
wiley   +1 more source

Red Blood Cell Survival in Patients with Aortic Valvular Disease and Ball-Valve Prostheses [PDF]

, 1965
Michael Brodeur, Donald W. Sutherland, Robert D. Koler, Albert Starr, Jean Kimsey, Herbert E. Griswold   +5 more
openalex   +1 more source

Three‐Cusp View Orientation in TAVI: Evaluating LOA Versus Non‐LOA Impact on Outcomes With Contemporary Valve Prostheses

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Optimal projection views during transcatheter aortic valve implantation (TAVI) procedures are critical for procedural success and patient outcomes. Aims This study investigated the influence of 3‐cusp view orientation—line of alignment (LOA) versus non‐LOA—on procedural outcomes in patients undergoing TAVI with contemporary ...
Rim Kasem Ali Sliman, Amnon Eitan, Keren Zisman, Yuval Avidan, Amir Aker, Hussein Sliman   +5 more
wiley   +1 more source

Aortic Homograft Valve Replacement [PDF]

, 1969
Brian G. Barratt‐Boyes, A Roche, Peter W.T. Brandt, J. C. Smith, J. B. Lowe   +4 more
openalex   +1 more source

Lessons Learned From the ACURATE IDE Trial for Transcatheter Aortic Valve Replacement

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The recent voluntary withdrawal of the ACURATE neo2 transcatheter aortic valve replacement device by Boston Scientific offers a compelling case study in the complex interplay of device design, clinical evidence, regulatory requirements, and market dynamics in modern structural heart interventions.
Arturo Giordano, Giuseppe Biondi‐Zoccai, David J. Cohen, Rodrigo Bagur, Nicola Corcione   +4 more
wiley   +1 more source

Transcatheter versus surgical aortic-valve replacement in high-risk patients.

New England Journal of Medicine, 2011
Craig R. Smith, M. Leon, M. Mack, D. C. Miller, J. Moses, L. Svensson, E. Tuzcu, J. Webb, G. Fontana, R. Makkar, Mathew William, T. Dewey, S. Kapadia, V. Babaliaros, V. Thourani, P. Corso, A. Pichard, J. Bavaria, H. Herrmann, J. Akin, W. Anderson, Duolao Wang, S. Pocock   +22 more
semanticscholar   +1 more source

STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement.

Journal of the American College of Cardiology, 2020
John D. Carroll, M. Mack, S. Vemulapalli, H. Herrmann, T. Gleason, G. Hanzel, G. Deeb, V. Thourani, D. Cohen, N. Desai, A. Kirtane, S. Fitzgerald, J. Michaels, Carole Krohn, F. Masoudi, R. Brindis, J. Bavaria   +16 more
semanticscholar   +1 more source

Site‐Specific Antithrombotic Therapy: 24‐Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple‐Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background DESyne BDS Plus represents a novel triple drug therapy (TRx) applied on a coronary stent platform eluting the antiproliferative drug Sirolimus along with two anticoagulants (Rivaroxaban and Argatroban) to reduce the site‐specific thrombotic risk.
Stefan Verheye, Bert Ferdinande, Johan Bennett, Rodolfo Staico, Seif El‐Jack, Pim A. L. Tonino, Alexandre Abizaid, Ian Buysschaert, Douglas Scott, Madhav Menon, Gerard Wilkins, Dougal McClean, Tomas Kovarnik, Uwe Christians, Antoinette Neylon, Zlatko Mehmedbegovic, Pieter C. Smits, Marie‐Claude Morice, Mark Webster, the DESyne BDS Plus RCT Investigators   +19 more
wiley   +1 more source